Jyske Realkredit A/S
23.3.2026 13:15:49 CET | Globenewswire | Press release
Final terms for bonds to be listed 24th March 2026
Final terms for bonds to be listed 24th March 2026
To Nasdaq Copenhagen A/S 23 March 2026
Announcement no. 26/2026
Final terms for bonds to be listed 24th March 2026
On 24th March 2026, Jyske Realkredit A/S will be listing 4 new Covered Bonds (SDO) and 1 Mortgage Bond (RO). Final terms for the bonds are attached to this announcement.
The full prospectus for the Bonds consists of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated June 27th 2025.
Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.com
Yours sincerely,
Jyske Realkredit
Please observe that the Danish version of this announcement prevails.
Attachments
- DK0009418832 - Final terms series 1 321.E.ja.28 IT1
- DK0009418915 - Final terms series 1 321.E.EUR.ja.28 IT1
- DK0009419053 - Final terms series 1 321.B.ja.28 RF
- DK0009419137 - Final terms series 422.E.OA Cb3 ju.30 RF
- DK0009419210 - Final terms series 1 111.E.59
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Zymeworks Inc.24.10.2026 08:30:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom